Merit Medical Systems Cash on Hand 2010-2023 | MMSI
Merit Medical Systems cash on hand from 2010 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Merit Medical Systems Annual Cash on Hand (Millions of US $) |
2023 |
$587 |
2022 |
$58 |
2021 |
$68 |
2020 |
$57 |
2019 |
$44 |
2018 |
$67 |
2017 |
$32 |
2016 |
$19 |
2015 |
$4 |
2014 |
$7 |
2013 |
$7 |
2012 |
$10 |
2011 |
$10 |
2010 |
$4 |
2009 |
$6 |
Merit Medical Systems Quarterly Cash on Hand (Millions of US $) |
2023-12-31 |
$587 |
2023-09-30 |
$59 |
2023-06-30 |
$72 |
2023-03-31 |
$58 |
2022-12-31 |
$58 |
2022-09-30 |
$51 |
2022-06-30 |
$63 |
2022-03-31 |
$54 |
2021-12-31 |
$68 |
2021-09-30 |
$69 |
2021-06-30 |
$70 |
2021-03-31 |
$59 |
2020-12-31 |
$57 |
2020-09-30 |
$45 |
2020-06-30 |
$50 |
2020-03-31 |
$50 |
2019-12-31 |
$44 |
2019-09-30 |
$37 |
2019-06-30 |
$35 |
2019-03-31 |
$50 |
2018-12-31 |
$67 |
2018-09-30 |
$52 |
2018-06-30 |
$44 |
2018-03-31 |
$34 |
2017-12-31 |
$32 |
2017-09-30 |
$23 |
2017-06-30 |
$38 |
2017-03-31 |
$26 |
2016-12-31 |
$19 |
2016-09-30 |
$17 |
2016-06-30 |
$10 |
2016-03-31 |
$5 |
2015-12-31 |
$4 |
2015-09-30 |
$6 |
2015-06-30 |
$12 |
2015-03-31 |
$10 |
2014-12-31 |
$7 |
2014-09-30 |
$6 |
2014-06-30 |
$9 |
2014-03-31 |
$13 |
2013-12-31 |
$7 |
2013-09-30 |
$9 |
2013-06-30 |
$13 |
2013-03-31 |
$9 |
2012-12-31 |
$10 |
2012-09-30 |
$9 |
2012-06-30 |
$10 |
2012-03-31 |
$10 |
2011-12-31 |
$10 |
2011-09-30 |
$6 |
2011-06-30 |
$63 |
2011-03-31 |
$3 |
2010-12-31 |
$4 |
2010-09-30 |
$5 |
2010-06-30 |
$4 |
2010-03-31 |
$6 |
2009-12-31 |
$6 |
2009-09-30 |
$6 |
2009-06-30 |
$5 |
2009-03-31 |
$16 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$4.299B |
$1.257B |
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|